Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Lung Cancer

UNC Football Player Tylee Craft Dies From Rare Cancer

North Carolina football player Tylee Craft, 23, passes away after battling rare lung cancer, leaving a lasting impact on his team and community.

Top News

North Carolina football player Tylee Craft dies from rare lung cancer at 23

North Carolina football player Tylee Craft has died from a rare form of lung cancer

The Independent UK

North Carolina Wide Receiver Tylee Craft Dies From Lung Cancer at 23

The Tar Heels honored the late 23-year-old during Saturday's game.

Sports Illustrated

From analysis to the latest developments in health,
read the most diverse news in one place.

Launders Lane: Incurable lung cancer sufferer fears she will die before seeing toxic fire put out

‘Time is running out’ - Frustrated and sick residents demand council action over toxic fire left to burn for 20 years

The Independent UK

Pat Woepse, husband of US women's water polo star Maddie Musselman, dies from rare cancer

U.S. women’s water polo star Maddie Musselman Woepse is mourning the loss of her husband, Pat, who died from a rare form of lung cancer

The Independent UK

NHS Scotland accepts 'game-changer' drugs to treat prostate and lung cancers

Treatments for different types of cancer and a life-threatening fungal infection are among those to have been accepted for use on the NHS in…

The National (Scotland)

‘Amazing’ trial shows drug combination stops lung cancer advancing for longer

Exclusive: Global trial finds treatment with amivantamab and lazertinib halts progression for average of 23.7 months

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Access to a GP can make all the difference in surviving lung cancer – and that is a problem for Māori

Surviving lung cancer in Aotearoa New Zealand could depend on whether you can access a GP – raising questions about equity in the country’s health system.

The Conversation

Novel Antibody May Be Key To Better Lung Cancer Treatment

Researchers develop synthetic antibody that, combined with Osimertinib, can prevent relapse of adenocarcinoma tumors in mouse models.

Zenger

Risk of lung cancer from radiotherapy doubles for breast cancer patients who smoke

Non-smokers found to have 1% chance of treatment leading to disease compared with between 2% and 6% for smokers

The Guardian - UK

Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths

Biotech stocks Nuvalent and Iteos diverged Monday on updates for their lung cancer treatments at the ESMO meeting in Madrid.

Investors Business Daily

Up 1,123% YTD, Is It Too Late to Buy This Breakout Biotech Stock?

Summit Therapeutics is a clinical-stage biotech company that has returned over 1,100% in 2024. Is the stock still a good buy right now?

Barchart

Merck Dives After Summit — Up 56% — Sneaks In With Keytruda-Walloping Punch

Merck stock tumbled Monday after Summit Therapeutics' cancer drug outperformed blockbuster Keytruda in a study of lung cancer patients.

Investors Business Daily

World-first lung cancer vaccine given to UK patient ...Tech & Science Daily podcast

Listen here on your chosen podcast platform.

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

The lung cancer signs everyone needs to know about as new vaccine announced

Researchers have said that BioNTech’s BNT116 vaccine could improve survival rates

The Guardian - UK

World-first lung cancer vaccine trials launched across seven countries

First patient in UK gets dose of jab designed to kill most common form of lung cancer – and stop it coming back

The Independent UK

Lung cancer vaccine: Breakthrough jab could improve survival rates

The vaccine, known as BNT116, utilises messenger RNA (mRNA), the same technology used in the Covid jab

The Independent UK

Man whose lung cancer was found ‘by coincidence’ first to have jab for disease

Janusz Racz, who lives in London, received the vaccine as part of a phase one clinical trial.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Lung cancer vaccine: How does it work?

The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.

Fortune

Susan Wojcicki blazed a trail for women in Silicon Valley

The former YouTube CEO died at 56 after two years living with lung cancer.

Fortune

Former YouTube CEO Susan Wojcicki has died at 56

Wojcicki, one of the most influential female executives in Silicon Valley, had been living with lung cancer for two years.

International Business Times

Former YouTube CEO Susan Wojcicki Dies Of Cancer Aged 56

Tech pioneer and former YouTube chief Susan Wojcicki, who played an instrumental role in the rise of Google, has died at the age of 56 after battling lung cancer, her husband announced Friday.

Top News

Former Youtube CEO Susan Wojcicki Passes Away After Cancer Battle

Former YouTube CEO Susan Wojcicki, a tech pioneer and influential figure in Google's history, has passed away after battling lung cancer. Her legacy as a l...

The Conversation

Engineered stone is now banned. But how safe are the alternatives?

From today, engineered stone is banned in Australia in a bid to protect workers from inhaling deadly silica dust, which has long been linked to diseases such as lung cancer and silicosis.

Dynamite News

Researchers find how precision radiation treatment supports in lung cancer

For patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more accurate intensity-modulated radiation therapy (IMRT) is recommended over the alternative 3D-conformal radiation therapy (3D-CRT). Read further on Dynamite News:

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University College London

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.